SIETES :: 92261 citas

Resultados de la búsqueda por D REFINAR BÚSQUEDA

1.

2.

3.

Schröder C, Dörks M, Kollhorst B, Blenk T, Dittmann RW, Garbe E, Riedel O. Outpatient antidepressant drug use in children and adolescents in Germany between 2004 and 2011. Pharmacoepidemiol Drug Saf 2017;26:170-9. [Ref.ID 101952]

4.

Jobski K, Schmedt N, Kollhorst B, Krappweis J, Schink T, Garbe E. Characteristics and drug use patterns of older antidepressant initiators in Germany. Eur J Clin Pharmacol 2017;73:105-13. [Ref.ID 101939]

5.

Rejón R. Las aseguradoras de EE UU han logrado mejor precio que los gobiernos europeos para la cura de la hepatitis C . eldiario.es 2016:1. [Ref.ID 100694]

6.

Ekstam AK, Elmståhl S. Do fall-risk-increasing drugs have an impact on mortality in older hip fracture patients? A population-based cohort study. Clinical Interventions in Aging 2016;11:489-96. [Ref.ID 100216]

7.

Litonjua AA, Carey VJ, Laranjo N, Harshfield BJ, McElrath TF, O'Connor GT, Sandel M, Iverson Jr RE, Lee-Paritz A, Strunk RC, Bacharier LB, Macones GA, Zeiger RS, Schatz M, Hollis BW, Hornsby E, Hawrylowicz C, Wu AC, Weiss ST. Effect of prenatal supplementation with vitamin D on asthma or recurrent wheezing in offspring by age 3 years: the VDAART randomized clinical trial. JAMA 2016;315:362-70. [Ref.ID 100092]

8.

Chawes BL, Bonnelykke K, Stokholm J, Vissing NH, Bjarnadóttir E, Schoos A-MM, Wolsk HM, Pedersen TM, Vinding RK, Thorsteinsdóttir S, Arianto L, Hallas HW, Heickendorff L, Brix S, Rasmussen MA, Bisgaard H. Effect of vitamin D3 supplementation during pregnancy on risk of persistent wheeze in the offspring: a randomized clinical trial. JAMA 2016;315:353-61. [Ref.ID 100091]

9.

von Mutius E, Martínez FD. Inconclusive results of randomized trials of prenatal vitamin D for asthma prevention in offspring: curbing the enthusiasm. JAMA 2016;315:347-8. [Ref.ID 100090]

10.

Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, Staehelin HB, Meyer OW, Theiler R, Dick W, Willett WC, Egli A. Monthly high-dose vitamin D treatment for the prevention of functional decline. A randomized clinical trial. JAMA Intern Med 2016;176:febrero. [Ref.ID 100025]

11.

Cummings SR, Kiel DP, Black DM. Vitamin D supplementation and increased risk of falling. A cautionary tale of vitamin supplements retold. JAMA Intern Med 2016;176:febrero. [Ref.ID 100024]

12.

Buettner C, Nir RR, Bertisch SM, Bernstein C, Schain A, Mittleman MA, Burstein R. Simvastatin and vitamin D for migraine prevention: a randomized controlled trial. Ann Neurol 2015;78:970-81. [Ref.ID 99785]

13.

Meier F, Maas R, Sonst A, Patapovas A, Müller F, Plank-Kiegele B, Pfistermeister B, Schöffski O, Bürkle T, Dormann H. Adverse drug events in patients admitted to an emergency department: an analysis of direct costs. Pharmacoepidemiol Drug Saf 2015;24:176-86. [Ref.ID 99600]

14.

Grey A, Bolland M. Web of industry, advocacy, and academia in the management of osteoporosis. BMJ 2015;351:h3170. [Ref.ID 99391]

15.

Anónimo. Recombinant human parathyroid hormone (Natpara). Med Lett Drugs Ther 2015;57:87-8. [Ref.ID 99227]

16.

LeBlanc ES, Chou R. Vitamin D and falls—Fitting new data with current guidelines. JAMA Intern Med 2015;175:712-3. [Ref.ID 98874]

17.

Uusi-Rasi K, Patil R, Karinkanta S, Kannus P, Tokola K, Lamberg-Allardt C, Sievänen H. Exercise and vitamin D in fall prevention among older women. A randomized clinical trial. JAMA Intern Med 2015;175:703-11. [Ref.ID 98871]

18.

Anónimo. Relatos salvajes del primer mundo. Farmacología virtual 2015;9:1. [Ref.ID 98859]

19.

Anónimo. Sucroferric oxyhydroxide (Velphoro) for hyperphosphatemia. Drug Ther Bull 2014;56:76-7. [Ref.ID 98173]

20.

LeBlanc E, Chou R, Zakher B, Daeges M, Pappas M. Screening for vitamin D deficiency: systematic evidence review of the U.S. Preventive Services Task Force recommendation. U.S. Preventive Services Task Force 2014:junio. [Ref.ID 97711]